U.S. Veterinary Surgical Instruments Market Size Analysis

U.S. Veterinary Surgical Instruments Market Size- By Product, By Animal Type, By Application – Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published: Jan-2026	Report ID: MEDE2612	Pages: 1 - 149	Formats^*:
Category : Medical Devices

According to SPER Market Research, the U.S. Veterinary Surgical Instruments Market is estimated to reach USD 1212.73 million by 2034 with a CAGR of 6.85%.

Introduction and Overview

The insect protein market in North America was estimated to be worth USD 625.2 million in 2024 and is projected to increase at a compound annual growth rate (CAGR) of 6.85% to reach by 2034. The U.S. market is witnessing strong growth due to the expanding population of both companion and livestock animals, along with rising spending on animal healthcare and veterinary services. Increased awareness around animal well-being has boosted demand for advanced veterinary care, including surgical procedures. Additionally, the growing prevalence of chronic conditions in animals—such as cancer, joint disorders, mobility issues, and heart-related diseases—has further increased the need for effective treatment options, particularly surgical interventions, thereby supporting overall market expansion.

By Product:

Based on product type, the U.S. market includes sutures and staplers, forceps, scalpels, surgical scissors, hooks and retractors, trocars and cannulas, electrosurgical instruments, and other tools. Among these, electrosurgical instruments lead the market due to their growing use in modern veterinary procedures. These tools offer greater precision, improved safety, and reduced blood loss compared to conventional instruments. They also minimize tissue damage, post-operative pain, and swelling. Moreover, integration with advanced digital systems enables controlled energy delivery, enhancing surgical accuracy and overall treatment quality in animal care.

By Animal type:

Based on animal type, the U.S. veterinary surgical instruments market is segmented into companion animals, livestock animals, and exotic and zoo animals. Companion animals account for the largest share, driven by the high and growing adoption of pets such as dogs, cats, horses, and other small animals. A substantial portion of households own pets, leading to increased spending on animal healthcare. Additionally, the rising prevalence of chronic conditions like cancer and other long-term diseases among pets has increased the need for surgical interventions. Greater owner willingness to invest in advanced and preventive veterinary care further supports segment growth.

By Application:

Based on application, the U.S. veterinary surgical instruments market is segmented into soft tissue surgery, sterilization surgery, dental surgery, orthopedic surgery, ophthalmic surgery, and other procedures. Soft tissue surgery represents the leading segment due to the high volume of procedures involving organs, skin, and internal systems. Common interventions include hernia repair, tumor and mass removal, and dermatological treatments, along with advanced procedures such as abdominal explorations and organ-related surgeries. The steady need for these treatments drives strong demand for essential instruments like scalpels, forceps, scissors, and retractors. Additionally, the expanding pet population and rising owner spending on animal health continue to support growth in this segment.

By end use:

Based on end use, the U.S. veterinary surgical instruments market is segmented into veterinary hospitals, veterinary clinics, academic and research institutes, and other users. Veterinary hospitals account for the largest share of the market and are expected to witness steady growth over the forecast period. This dominance is driven by the rising demand for advanced and specialized surgical procedures in animal healthcare. Veterinary hospitals serve as the primary point of care for a high volume of animal visits, leading to greater utilization of surgical instruments. Moreover, the availability of experienced veterinary professionals enhances pet owner trust and preference for these facilities, further supporting market growth.

Regional Insights

The South Atlantic region leads the U.S. veterinary surgical instruments market, supported by strong demand across key states. Florida holds a dominant position due to its large pet-owning population and well-established veterinary service culture. The high concentration of households with pets drives demand for advanced veterinary care, including surgical procedures. Additionally, a robust veterinary infrastructure and focus on professional training further strengthen the state’s market presence. Georgia is also expected to experience notable growth, driven by a dense network of veterinary clinics, animal hospitals, and renowned academic institutions that actively invest in advanced surgical tools and technologies for both companion and livestock animal care.

Market Competitive Landscape

The U.S. veterinary surgical instruments market is highly fragmented, featuring a mix of established leaders, emerging companies, and local players focused on innovation and technological advancement. Key industry participants include B. Braun Vet Care, Medtronic, Ethicon, and Vimian Group, which together account for a significant portion of overall market revenue. These companies provide broad product portfolios, ranging from basic surgical tools to advanced electrosurgical systems. Alongside them, specialized players such as Jorgensen Laboratories, Sklar Surgical Instruments, and GerMedUSA cater to niche surgical needs by offering customized and application-specific veterinary solutions.

Recent Developments:

In September, Vimian Group expanded into the veterinary dental segment by acquiring iM3, a global supplier of veterinary dental products and equipment. This move strengthens Vimian’s MedTech portfolio by adding dental instruments, imaging solutions, and consumables to meet growing demand for animal dental care.
In June, Movora finalized the integration of NGD operations into its facilities, making the complete NGD product portfolio available through Movora’s online platforms in the U.S. and Canada. This integration enhances Movora’s presence in the veterinary MedTech market and broadens its product range to better support veterinary clinics across both regions.

Scope of the report:

Report Metric	Details
Market size available for years	2021-2034
Base year considered	2024
Forecast period	2025-2034
Segments covered	By Product, By Animal Type, By Application
Regions covered	East, West, South, North
Companies Covered	Arthrex, Avante Animal Health (Avante Health Solutions), B. Braun Vet Care, Ethicon (Johnson & Johnson), Integra LifeSciences, Medtronic, Neogen Corporation, STERIS, Smiths Medical, Vimian Group, Jørgen Kruuse (Henry Schein), Surgical Holdings.

1. Introduction

1.1. Scope of the report

1.2. Market segment analysis

2. Research Methodology

2.1. Research data source

2.1.1. Secondary Data

2.1.2. Primary Data

2.1.3. SPER’s internal database

2.1.4. Premium insight from KOL’s

2.2. Market size estimation

2.2.1. Top-down and Bottom-up approach

2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis

5.1.1. Strengths

5.1.2. Weaknesses

5.1.3. Opportunities

5.1.4. Threats

5.2. PESTEL Analysis

5.2.1. Political Landscape

5.2.2. Economic Landscape

5.2.3. Social Landscape

5.2.4. Technological Landscape

5.2.5. Environmental Landscape

5.2.6. Legal Landscape

5.3. PORTER’s Five Forces

5.3.1. Bargaining power of suppliers

5.3.2. Bargaining power of buyers

5.3.3. Threat of Substitute

5.3.4. Threat of new entrant

5.3.5. Competitive rivalry

5.4. Heat Map Analysis

6. Competitive Landscape

6.1. U.S. Veterinary Surgical Instruments Market Manufacturing Base Distribution, Sales Area, Product Type

6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U.S. Veterinary Surgical Instruments Market

7. U.S. Veterinary Surgical Instruments Market, By Product (USD Million) 2021-2034

7.1. Sutures and staplers

7.2. Forceps

7.3. Scalpels

7.4. Surgical scissors

7.5. Hooks and retractors

7.6. Trocars and cannulas

7.7. Electro-surgery instruments

7.8. Other products

8. U.S. Veterinary Surgical Instruments Market, By Animal Type (USD Million) 2021-2034

8.1. Companion animals

8.1.1. Dogs

8.1.2. Cats

8.1.3. Horses

8.1.4. Other companion animals

8.2. Livestock animals

8.2.1. Cattle

8.2.2. Sheep and goats

8.2.3. Swine

8.2.4. Poultry

8.3. Exotic and zoo animals

9. U.S. Veterinary Surgical Instruments Market, By Application (USD Million) 2021-2034

9.1. Soft tissue surgery

9.2. Sterilization surgery

9.3. Dental surgery

9.4. Orthopedic surgery

9.5. Ophthalmic surgery

9.6. Other applications

10. U.S. Veterinary Surgical Instruments Market, By End Use (USD Million) 2021-2034

10.1. Veterinary hospitals

10.2. Veterinary clinics

10.3. Academic and research institutes

10.4. Other end use

11. U.S. Veterinary Surgical Instruments Market, By Region, (USD Million) 2021-2034

11.1.1. East

11.1.2. West

11.1.3. South

11.1.4. North

12. Company Profile

12.1. Arthrex

12.1.1. Company details

12.1.2. Financial outlook

12.1.3. Product summary

12.1.4. Recent developments

12.2. Avante Animal Health (Avante Health Solutions)

12.2.1. Company details

12.2.2. Financial outlook

12.2.3. Product summary

12.2.4. Recent developments

12.3. B. Braun Vet Care

12.3.1. Company details

12.3.2. Financial outlook

12.3.3. Product summary

12.3.4. Recent developments

12.4. Ethicon (Johnson & Johnson)

12.4.1. Company details

12.4.2. Financial outlook

12.4.3. Product summary

12.4.4. Recent developments

12.5. Integra LifeSciences

12.5.1. Company details

12.5.2. Financial outlook

12.5.3. Product summary

12.5.4. Recent developments

12.6. Medtronic

12.6.1. Company details

12.6.2. Financial outlook

12.6.3. Product summary

12.6.4. Recent developments

12.7. Neogen Corporation

12.7.1. Company details

12.7.2. Financial outlook

12.7.3. Product summary

12.7.4. Recent developments

12.8. STERIS

12.8.1. Company details

12.8.2. Financial outlook

12.8.3. Product summary

12.8.4. Recent developments

12.9. Smiths Medical

12.9.1. Company details

12.9.2. Financial outlook

12.9.3. Product summary

12.9.4. Recent developments

12.10. Vimian Group

12.10.1. Company details

12.10.2. Financial outlook

12.10.3. Product summary

12.10.4. Recent developments

12.11. Jørgen Kruuse (Henry Schein)

12.11.1. Company details

12.11.2. Financial outlook

12.11.3. Product summary

12.11.4. Recent developments

12.12. Surgical Holdings

12.12.1. Company details

12.12.2. Financial outlook

12.12.3. Product summary

12.12.4. Recent developments

12.13. Others

13. Conclusion

14. List of Abbreviations

15. Reference Links

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1